<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00087360</url>
  </required_header>
  <id_info>
    <org_study_id>FCCC-03030</org_study_id>
    <secondary_id>CDR0000374972</secondary_id>
    <nct_id>NCT00087360</nct_id>
  </id_info>
  <brief_title>Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants</brief_title>
  <official_title>Providing Genetic And Environmental Cancer Risk Assessment In Primary Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fox Chase Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Fox Chase Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Evaluating the knowledge and attitudes of healthy participants toward a new diet&#xD;
      and gene test for colorectal cancer risk may help doctors improve acceptance of colorectal&#xD;
      cancer screening.&#xD;
&#xD;
      PURPOSE: This clinical trial is studying the knowledge and attitudes of healthy participants&#xD;
      toward genetic and environmental risk assessment for colorectal cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
      Part 1&#xD;
&#xD;
        -  Determine the willingness of healthy participants to enroll in a genetic and&#xD;
           environmental risk assessment for colorectal cancer.&#xD;
&#xD;
        -  Determine the impact of decision counseling on knowledge and attitudes about genetic and&#xD;
           environmental risk assessment (GERA) and colorectal cancer screening in these&#xD;
           participants.&#xD;
&#xD;
        -  Determine participants' understanding of GERA.&#xD;
&#xD;
        -  Determine participants' response to GERA results.&#xD;
&#xD;
      Part 2&#xD;
&#xD;
        -  Determine awareness of, and interest in, diet and genetic assessment for colorectal&#xD;
           cancer among healthy participants at average risk for colorectal cancer who have not&#xD;
           undergone regular colon cancer screening.&#xD;
&#xD;
        -  Determine participants' level of knowledge of this assessment.&#xD;
&#xD;
        -  Determine participants' rate of acceptance into this study.&#xD;
&#xD;
      OUTLINE: This is a 2-part pilot study.&#xD;
&#xD;
        -  Part 1: Participants complete a baseline questionnaire on attitudes, beliefs, and&#xD;
           knowledge about colorectal cancer (CRC), CRC screening, and diet and genetic testing for&#xD;
           colorectal cancer risk. Two-four weeks later, participants are educated about CRC&#xD;
           screening options and undergo genetic and environmental risk assessment (GERA) decision&#xD;
           counseling about the methylene tetrahydrofolate reductase (MTHFR) gene and dietary&#xD;
           folate intake. Participants who decide to undergo GERA undergo blood testing for MTHFR&#xD;
           polymorphisms and folate levels. Participants whose blood tests indicate low folate&#xD;
           levels are further counseled about dietary folate intake.&#xD;
&#xD;
        -  Part 2: Participants complete a questionnaire on attitudes, beliefs, and knowledge about&#xD;
           CRC, CRC screening, and diet and genetic testing for colorectal cancer risk.&#xD;
&#xD;
      Participants in part 1 are followed at 1 week, 1 month, and then at 6 months.&#xD;
&#xD;
      PROJECTED ACCRUAL: A total of 110 participants (60 for part 1 and 50 for part 2) will be&#xD;
      accrued for this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2003</start_date>
  <completion_date type="Actual">May 2007</completion_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Colorectal cancer (CRC) screening rates by chart review at 4 months</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knowledge regarding CRC risk by questionnaires at 4 and 12 months</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRC risk perception by questionnaires at 4 and 12 months</measure>
  </secondary_outcome>
  <condition>Colorectal Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>counseling intervention</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>physiologic testing</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>evaluation of cancer risk factors</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Healthy participants&#xD;
&#xD;
          -  Eligible for colorectal cancer screening&#xD;
&#xD;
          -  No personal or family history of colorectal cancer&#xD;
&#xD;
               -  No more than 1 first-degree relative who has had colorectal cancer&#xD;
&#xD;
          -  Part 1:&#xD;
&#xD;
               -  Has not undergone regular screening for colorectal cancer&#xD;
&#xD;
          -  Part 2:&#xD;
&#xD;
               -  Not currently undergoing regular colon cancer testing, including any of the&#xD;
                  following:&#xD;
&#xD;
                    -  Fecal occult blood testing within the past year&#xD;
&#xD;
                    -  Flexible sigmoidoscopy or colonoscopy within the past 5 years&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
        Age&#xD;
&#xD;
          -  50 to 74&#xD;
&#xD;
        Performance status&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Life expectancy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hematopoietic&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hepatic&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Renal&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Other&#xD;
&#xD;
          -  No inflammatory bowel disease (part 1 only)&#xD;
&#xD;
          -  No concurrent health issues that would preclude study participation (part 1 only)&#xD;
&#xD;
          -  No history of cancer except basal cell or squamous cell skin cancer (part 2 only)&#xD;
&#xD;
          -  Able to speak and read English (part 2 only)&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
        Biologic therapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Chemotherapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Endocrine therapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Radiotherapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Surgery&#xD;
&#xD;
          -  Not specified&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Weinberg, MD, MSC</last_name>
    <role>Study Chair</role>
    <affiliation>Fox Chase Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892-1182</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kimmel Cancer Center at Thomas Jefferson University - Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107-5541</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fox Chase Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-0165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <study_first_submitted>July 8, 2004</study_first_submitted>
  <study_first_submitted_qc>July 9, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2004</study_first_posted>
  <last_update_submitted>July 10, 2013</last_update_submitted>
  <last_update_submitted_qc>July 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colon cancer</keyword>
  <keyword>rectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

